Clinical Trial Detail

NCT ID NCT03178552
Title A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Hoffmann-La Roche
Indications

lung squamous cell carcinoma

lung non-small cell carcinoma

Therapies

Entrectinib

Carboplatin + Cisplatin + Gemcitabine

Atezolizumab

Carboplatin + Cisplatin + Pemetrexed

Alectinib

Age Groups: senior adult

Additional content available in CKB BOOST